Insulin Resistance is Localized to Skeletal but Not Heart Muscle in Type 1 Diabetes
Overview
Authors
Affiliations
To determine the tissue localization of insulin resistance in type 1 diabetic patients, whole body and regional glucose uptake rates were determined under euglycemic hyperinsulinemic conditions. Leg, arm, and heart glucose uptake rates were measured using positron emission tomography-derived 2-deoxy-2-[18F]-fluoro-D-glucose kinetics and the three-compartment model described by Sokoloff et al. (L. Sokoloff, M. Reivich, C. Kennedy, M.C. DesRosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara. J. Neurochem. 28: 897-916, 1977) in eight type 1 diabetic patients and eight matched normal subjects. Whole body glucose uptake was quantitated by the euglycemic insulin clamp technique. Whole body glucose uptake was approximately 31% lower in the diabetic patients (P < 0.01) than in the normal subjects, thus confirming the presence of whole body insulin resistance. The rate of glucose uptake was approximately 45% lower in leg muscle when measured in the femoral region (55 +/- 7 vs. 102 +/- 13 mumol.kg muscle-1.min-1, diabetic patients vs. normal subjects, P < 0.05) and approximately 27% lower in the arm muscles (66 +/- 4 vs. 90 +/- 13 mumol.kg muscle-1.min-1, respectively, P < 0.05), whereas no difference was observed in heart glucose uptake [789 +/- 80 vs. 763 +/- 58 mumol.kg muscle-1.min-1 not significant (NS)]. Whole body glucose uptake correlated with glucose uptake in femoral (r = 0.93, P < 0.005) and arm muscles (r = 0.66, P < 0.05) but not with glucose uptake in the heart (r = 0.04, NS). We conclude that insulin resistance in type 1 diabetic patients is localized to skeletal muscle, whereas heart glucose uptake is unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
Bornstein M, Tian R, Arany Z Cell Metab. 2024; 36(7):1456-1481.
PMID: 38959861 PMC: 11290709. DOI: 10.1016/j.cmet.2024.06.003.
Vascular deficits contributing to skeletal fragility in type 1 diabetes.
Draghici A, Zahedi B, Taylor J, Bouxsein M, Yu E Front Clin Diabetes Healthc. 2023; 4:1272804.
PMID: 37867730 PMC: 10587602. DOI: 10.3389/fcdhc.2023.1272804.
Myostatin serum levels in children with type 1 diabetes mellitus.
Efthymiadou A, Vasilakis I, Giannakopoulos A, Chrysis D Hormones (Athens). 2021; 20(4):777-782.
PMID: 34486100 DOI: 10.1007/s42000-021-00317-y.
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.
Coleman S, Rebalka I, Dsouza D, Hawke T World J Diabetes. 2015; 6(17):1323-36.
PMID: 26674848 PMC: 4673386. DOI: 10.4239/wjd.v6.i17.1323.
To Lose Weight or Not to Lose Weight, That Is the Big Question--in Obesity-Related Heart Failure.
Peterson L Diabetes. 2015; 64(5):1509-10.
PMID: 25908877 PMC: 4407854. DOI: 10.2337/db15-0003.